The four hallmark signs of tumor lysis syndrome are hyperuricemia, hyperkalemia, hyperphosphatemia and?

NVS Staff Nurse - 2019

Medical & Surgical Nursing

Medium

Appeared in: NVS Staff Nurse - 2019

Explanation

Tumor Lysis Syndrome (TLS) is characterized by a specific set of metabolic disturbances caused by the rapid breakdown of malignant cells.
The lysis of these cells releases large amounts of intracellular phosphate into the bloodstream, causing hyperphosphatemia.
This excess phosphate binds avidly to serum calcium, forming insoluble calcium phosphate precipitates.
This binding process removes free ionized calcium from the circulation, resulting in a secondary or 'reciprocal' hypocalcemia.
Therefore, hypocalcemia is the fourth hallmark sign, occurring as a direct consequence of hyperphosphatemia.

Option A: Hyponatremia is not a primary hallmark sign of TLS. While it can occur in cancer patients, it is often related to the syndrome of inappropriate antidiuretic hormone (SIADH) or can be a consequence of the aggressive intravenous hydration used to treat TLS, which can dilute serum sodium.
Option B: Hypercalcemia is the opposite of what occurs in TLS. In TLS, serum calcium levels decrease. Hypercalcemia is a common metabolic emergency in oncology but is typically caused by bone metastases or the production of parathyroid hormone-related peptide (PTHrP) by tumors, not by cell lysis.
Option C: Hypernatremia is not a characteristic feature of TLS. Sodium balance is not directly affected by the process of tumor cell lysis.

Clinical Relevance

Nursing practice connection: Knowing Pathophysiology and hallmark signs of Tumor Lysis Syndrome (TLS) helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Recognizing the four hallmark signs of TLS is critical for nurses, as it is a life-threatening oncologic emergency requiring immediate intervention.
The primary nursing goals are prevention in high-risk patients (e.g., those with leukemia or lymphoma starting chemotherapy) and early detection through vigilant monitoring of labs and clinical status.
Patient safety is paramount. Nurses must monitor for signs of cardiac arrhythmia on the ECG (e.g., peaked T waves from hyperkalemia) and neuromuscular irritability (e.g., Chvostek's sign from hypocalcemia).

How to Approach the Question

First, identify the core concept of the question: the key metabolic changes in Tumor Lysis Syndrome (TLS).
Recall the pathophysiology of TLS: what happens when a large number of cells break open at once?
Think about the intracellular environment. Cells are rich in potassium and phosphate. When they lyse, these electrolytes flood the bloodstream, causing hyperkalemia and hyperphosphatemia.
Remember that the breakdown of cellular DNA and RNA (nucleic acids) produces purines, which are metabolized into uric acid, causing hyperuricemia.
Finally, connect the imbalances. The sudden high level of phosphate (hyperphosphatemia) causes a secondary problem. Phosphate binds with calcium, pulling it out of the blood. This leads to low calcium levels, or hypocalcemia.
Evaluate the options based on this pathophysiological sequence. Hypocalcemia is the only option that fits this cascade.

Concept Tested & Keywords

Concept Tested: Pathophysiology and hallmark signs of Tumor Lysis Syndrome (TLS)
Stem keywords: tumor lysis syndrome, hallmark signs, hyperuricemia, hyperkalemia, hyperphosphatemia
Lead-in keywords: and?
Negative lead-in flag: false

QOeOKRne3jaN7QcInbCBO-

E6 Medicine Harrison 22e Part 1 p. 634-636

E6 Nursing Brunner Adult Health 3SA Vol 2 Part 3 p. 79-81

E6 Medicine Davidson Principles Practice 24e p. 1348-1350